Prime Medicine, Inc. (PRME) Financials

PRME Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 249.0 million 209.2 million
March 31, 2026 294.7 million 218.0 million
Dec. 31, 2025 342.7 million 221.9 million
Sept. 30, 2025 385.0 million 223.2 million

PRME Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -41.1 million 4.9 million
March 31, 2026 -42.9 million 4.6 million
Dec. 31, 2025 -37.5 million 4.5 million
Sept. 30, 2025 -35.3 million 12.7 million

PRME Net Income

No data available :(

PRME Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 95.1 million - 112.5 million
March 31, 2026 135.5 million 106.0 million 8.5 million
Dec. 31, 2025 177.7 million 108.3 million 8.1 million
Sept. 30, 2025 208.4 million - 118.1 million

PRME Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 177.2 million
March 31, 2026 177.1 million
Dec. 31, 2025 148.8 million
Sept. 30, 2025 160.5 million

PRME Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 46000 33.4 million 11.0 million -
March 31, 2026 214000 34.1 million 17.4 million -
Dec. 31, 2025 290000 34.7 million 14.7 million -
Sept. 30, 2025 247000 44.0 million 11.2 million -

PRME Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.2 million -
March 31, 2026 856000 1.9 million
Dec. 31, 2025 838000 1.9 million
Sept. 30, 2025 1.2 million 44.0 million

PRME Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PRME

Price: $3.24

52 week price:
2.67
6.94

Earnings Per Share: -1.04 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 580.4 million

Links: